RekrutujeFaza III
Badanie fazy III leku MK-1084 i durvalumab
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Badane leki: MK-1084durvalumabcalderasib
+11
+11Rak płuca: badania kliniczne, Kraków
Badania kliniczne w obszarze: rak płuca, prowadzone w ośrodkach w mieście Kraków. Zobacz też wszystkie badania: rak płuca w Polsce.
31 badań: 31 rekrutuje.
Lista badań (strona 1 z 2)
RekrutujeFaza II
Badanie fazy II leku EIK1001 i pembrolizumab
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Badane leki: EIK1001pembrolizumab
+17
+17RekrutujeFaza II
Badanie fazy II leku GEN1184 i PRO1184
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Badane leki: GEN1184PRO1184
+6
+6RekrutujeObserwacyjne
Badanie obserwacyjne
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Badane leki: atezolizumab
RekrutujeFaza III
Badanie fazy III leku paclitaxel i paclitaxel albumin-bound
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic…
Badane leki: paclitaxelpaclitaxel albumin-boundpembrolizumabcarboplatin
+14
+14RekrutujeFaza II/III
Badanie fazy II/III leku cisplatin i amivantamab
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard…
Badane leki: cisplatinamivantamabosimertinibpemetrexed+15
+15RekrutujeFaza III
Badanie fazy III leku docetaxel i docetaxel monotherapy
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1)…
Badane leki: docetaxeldocetaxel monotherapy+21
+21RekrutujeFaza I/II
Badanie fazy I/II leku pemetrexed disodium i carboplatin
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer…
Badane leki: pemetrexed disodiumcarboplatinBNT327pembrolizumab
+3
+3RekrutujeFaza II/III
Badanie fazy II/III leku pembrolizumab i navlimetostat
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic…
Badane leki: pembrolizumabnavlimetostatcisplatincarboplatin
+29
+29RekrutujeFaza II
Badanie fazy II leku BNT324 i BNT327
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Badane leki: BNT324BNT327
+2
+2RekrutujeFaza II
Badanie fazy II leku HLX43
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
Badane leki: HLX43+2
+2RekrutujeFaza III
Badanie fazy III leku cisplatin i pembrolizumab
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Badane leki: cisplatinpembrolizumabcarboplatinpemetrexed+16
+16RekrutujeFaza III
Badanie fazy III leku cisplatin i pemetrexed
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell…
Badane leki: cisplatinpemetrexedadagrasibpembrolizumab
+27
+27RekrutujeFaza III
Badanie fazy III leku carboplatin i pemetrexed
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously…
Badane leki: carboplatinpemetrexedcisplatindivarasib
+20
+20RekrutujeFaza III
Badanie fazy III leku tislelizumab i docetaxel
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic…
Badane leki: tislelizumabdocetaxelN-803
+8
+8RekrutujeFaza II/III
Badanie fazy II/III leku paclitaxel i BNT327
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Badane leki: paclitaxelBNT327pembrolizumabpemetrexed disodium+14
+14RekrutujeFaza III
Badanie fazy III leku atezolizumab i BNT327
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Badane leki: atezolizumabBNT327carboplatincisplatin
+6
+6RekrutujeFaza III
Badanie fazy III leku cisplatin i paclitaxel
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Badane leki: cisplatinpaclitaxelgemcitabine hydrochloridecarboplatin
+23
+23RekrutujeFaza III
Badanie fazy III leku sacituzumab tirumotecan i carboplatin
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Badane leki: sacituzumab tirumotecancarboplatinpaclitaxel albumin-bounddexamethasone acetate+18
+18RekrutujeFaza III
Badanie fazy III leku cisplatin i osimertinib
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally…
Badane leki: cisplatinosimertinibdatopotamab deruxtecancarboplatin
+19
+19RekrutujeFaza III
Badanie fazy III leku MK-1084 i pembrolizumab
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1)…
Badane leki: MK-1084pembrolizumabcalderasib+23
+23RekrutujeFaza III
Badanie fazy III leku gemcitabine hydrochloride i carboplatin
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC)…
Badane leki: gemcitabine hydrochloridecarboplatinpembrolizumabpemetrexed disodium+23
+23RekrutujeFaza III
Badanie fazy III leku pembrolizumab i sacituzumab tirumotecan
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand…
Badane leki: pembrolizumabsacituzumab tirumotecandexamethasone+18
+18RekrutujeFaza III
Badanie fazy III leku pembrolizumab i sotorasib
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced…
Badane leki: pembrolizumabsotorasibpemetrexeddexamethasone+31
+31RekrutujeFaza III
Badanie fazy III leku topotecan i trilaciclib
Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan
Badane leki: topotecantrilaciclib+2
+2RekrutujeFaza I/II
Badanie fazy I/II leku budesonide i pemetrexed
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously…
Badane leki: budesonidepemetrexedpembrolizumabdivarasib+10
+10RekrutujeFaza II
Badanie fazy II leku durvalumab i carboplatin
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
Badane leki: durvalumabcarboplatincisplatinpaclitaxel
RekrutujeFaza I
Badanie fazy I leku durvalumab i cisplatin
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Badane leki: durvalumabcisplatincarboplatinpemetrexed+11
+11RekrutujeFaza II/III
Badanie fazy II/III leku adagrasib i pembrolizumab
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Badane leki: adagrasibpembrolizumab+39
+39RekrutujeFaza I
Rak prostaty: badanie fazy I leku enzalutamide i itraconazole
Mevrometostat Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Badane leki: enzalutamideitraconazole
Rak płuca: inne miasta
Nie wiesz, które badanie jest dla Ciebie?
Zadzwoń i porozmawiaj z doradcą ds. badań klinicznych. Sprawdzimy w rejestrach, do których badań możesz się kwalifikować.
Zadzwoń do naszego specjalisty+48 664 930 800pon-pt: 9:00 - 18:00
Wolisz, żebyśmy oddzwonili? Zostaw numer
Nie udzielamy porad ani konsultacji medycznych. Pomagamy znaleźć badanie i skontaktować się z ośrodkiem.
Informacje pochodzą z publicznych rejestrów badań klinicznych (CTIS - Unia Europejska, ClinicalTrials.gov - USA) i są aktualizowane codziennie. Mogą różnić się od aktualnego stanu w ośrodku. Ostateczną kwalifikację do badania zawsze przeprowadza lekarz w ośrodku badawczym. Stan na 3 października 2026.